查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1668045

有機藥用輔料市場 - 全球行業規模、佔有率、趨勢、機會和預測，按類型、功能、應用、地區和競爭細分，2020-2030 年

Organic Pharmaceutical Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Function, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球有機藥用輔料市場價值為 103.5 億美元，預計到 2030 年將達到 165 億美元，複合年成長率為 8.06%。藥用輔料是添加到藥物配方中以增強其穩定性、生物利用度和整體性能的非活性物質。由於對有機和清潔標籤藥品的需求不斷增加，源自天然來源的有機藥用輔料受到了廣泛關注。

市場概況
預測期 2026-2030
2024 年市場規模 103.5 億美元
2030 年市場規模 165億美元
2025-2030 年複合年成長率 8.06%
成長最快的領域 口服製劑
最大的市場 北美洲

該市場成長的主要驅動力之一是消費者對藥品中有機和天然成分的認知和偏好不斷提高。隨著人們越來越注重健康並擔心合成添加劑的潛在副作用，人們開始明顯轉向有機賦形劑。這一趨勢與更廣泛意義上的清潔和永續醫療保健解決方案的發展趨勢相一致，推動了對有機藥用輔料的需求。

此外，全球各地的監管機構一直在提倡使用更安全、更環保的輔料，進一步推動有機替代品市場的發展。這些賦形劑通常來自植物材料，例如纖維素、澱粉和樹膠，為藥物配方提供了永續且環保的選擇。

此外，製藥業持續的研究和開發努力，加上生物技術和奈米技術的進步，為創新有機輔料配方創造了機會。這些創新旨在解決藥物輸送、溶解度和生物利用度的特定挑戰，為有機輔料在新型藥物製劑開發中發揮關鍵作用打開了大門。

主要市場促進因素

消費者對有機產品的偏好日益增加

主要市場挑戰

有機原料供應有限且變動多端

主要市場趨勢

消費者對清潔標示藥品的需求不斷成長

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球有機藥用輔料市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（油脂化學品、碳水化合物、石化產品；蛋白質、其他）
    • 依功能分類（黏合劑、塗層劑、著色劑、崩解劑、其他功能）
    • 依應用分類（口服製劑、外用製劑、腸外製劑、其他應用）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按類型
    • 按功能
    • 按應用
    • 按地區

第5章：亞太有機藥用輔料市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型
    • 按功能
    • 按應用
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章：歐洲有機藥用輔料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章：北美有機藥用輔料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第 8 章：南美洲有機藥用輔料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第9章：中東和非洲有機藥用輔料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 驅動程式
  • 挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 12 章：全球有機藥用輔料市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Roquette Freres SA
  • DuPont de Nemours Inc.
  • Ashland Inc.
  • BASF SE
  • Kerry Group plc
  • Evonik Industries AG
  • Croda International plc
  • The Lubrizol Corporation
  • Innophos Holdings Inc.
  • Wacker Chemie AG

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 18970

Global Organic Pharmaceutical Excipients Market was valued at USD 10.35 Billion in 2024 and is expected to reach USD 16.50 Billion in the forecast period with a CAGR of 8.06% through 2030. The Global Organic Pharmaceutical Excipients Market is a dynamic and rapidly evolving sector within the pharmaceutical industry, poised for substantial growth in the coming years. Pharmaceutical excipients are inactive substances that are added to drug formulations to enhance their stability, bioavailability, and overall performance. Organic pharmaceutical excipients, derived from natural sources, have gained significant attention due to the increasing demand for organic and clean-label pharmaceutical products.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 10.35 Billion
Market Size 2030USD 16.50 Billion
CAGR 2025-20308.06%
Fastest Growing SegmentOral Formulations
Largest MarketNorth America

One of the key drivers of this market's growth is the rising consumer awareness and preference for organic and natural ingredients in pharmaceuticals. As individuals become more health-conscious and concerned about the potential side effects of synthetic additives, there has been a notable shift towards organic excipients. This trend aligns with the broader movement towards clean and sustainable healthcare solutions, driving the demand for organic pharmaceutical excipients.

Additionally, regulatory bodies across the globe have been advocating for the use of safer and more environmentally friendly excipients, further propelling the market for organic alternatives. These excipients, often sourced from plant-based materials such as cellulose, starch, and gums, offer a sustainable and eco-friendly option for pharmaceutical formulation.

Furthermore, the pharmaceutical industry's ongoing research and development efforts, coupled with advancements in biotechnology and nanotechnology, have created opportunities for innovative organic excipient formulations. These innovations aim to address specific challenges in drug delivery, solubility, and bioavailability, opening doors for organic excipients to play a crucial role in the development of novel drug formulations.

Key Market Drivers

Increasing Consumer Preference for Organic Products

The increasing consumer preference for organic products is a significant driving force behind the growing global organic pharmaceutical excipients market. In recent years, there has been a discernible shift in consumer attitudes towards health and wellness, leading to a heightened demand for organic and natural alternatives in various aspects of life, including pharmaceuticals.

Consumers today are more health-conscious and discerning than ever before. They are increasingly concerned about the potential side effects and health risks associated with synthetic ingredients and additives in pharmaceutical products. This heightened awareness has led to a growing preference for clean-label medications formulated with organic pharmaceutical excipients. These organic excipients, often sourced from natural materials like cellulose, starch, and gums, are considered safer and more aligned with the principles of holistic health and well-being.

The desire for transparency and clean ingredients in pharmaceuticals has become a central factor in consumer choices. Organic excipients offer the assurance of a natural and sustainable approach to medication, which resonates with consumers seeking healthier alternatives. Furthermore, organic pharmaceutical excipients are generally free from allergens and contaminants, which makes them a safer choice for individuals with sensitivities or allergies. Regulatory bodies have also recognized the importance of organic excipients in pharmaceutical formulations, aligning their guidelines and recommendations with consumer preferences. This convergence of consumer demand and regulatory support has created a conducive environment for the growth of the global organic pharmaceutical excipients market..

In response to the increasing prevalence of GERD, the Global Organic Pharmaceutical Excipients Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Limited Availability and Variability of Organic Raw Materials

The global organic pharmaceutical excipients market is experiencing robust growth, driven by the rising demand for natural and sustainable pharmaceutical products. Organic excipients, sourced from natural materials like plants and starches, are gaining popularity for their clean-label appeal and eco-friendly attributes. However, one of the key challenges hindering the growth of this market is the limited availability and variability of organic raw materials.

Organic excipients are primarily derived from natural sources, and their quality and availability are influenced by various factors, including climate, soil conditions, and agricultural practices. Unlike synthetic excipients, which can be manufactured with a high degree of precision and consistency, organic raw materials are subject to the vagaries of nature. This inherent variability can pose several challenges for the pharmaceutical industry.

The limited availability of organic raw materials can lead to supply chain disruptions. The production of organic excipients relies on a steady and sustainable supply of organic feedstock. When these raw materials are in short supply due to factors such as adverse weather conditions or fluctuations in crop yields, pharmaceutical manufacturers may face delays in production or increased costs as they seek alternative sources.

the variability in the quality and composition of organic raw materials can impact the consistency of organic excipients. Pharmaceutical formulations require precise and predictable properties to ensure the safety and efficacy of medications. Variability in excipient characteristics can make it challenging to achieve the desired drug formulation attributes, leading to concerns about product performance and patient safety.

Moreover, the variability of organic raw materials can also affect the cost of production. Pharmaceutical companies may need to invest in rigorous quality control processes to mitigate the impact of variations in organic excipients. This additional quality control can lead to increased production costs, potentially making organic excipients less competitive compared to their synthetic counterparts.

Key Market Trends

Rising Consumer Demand for Clean-Label Pharmaceuticals

The rising consumer demand for clean-label pharmaceuticals is a pivotal driver behind the burgeoning global organic pharmaceutical excipients market. In recent years, consumers have become increasingly health-conscious and discerning about the products they consume, including medications. This shift in consumer preferences towards clean-label pharmaceuticals, which are characterized by transparent ingredient lists containing natural and organic components, has created a substantial surge in demand for organic excipients.

Consumers are now more than ever concerned about the safety and efficacy of the medications they take, as well as the potential side effects of synthetic additives and artificial ingredients. They are actively seeking pharmaceutical products that align with their preference for natural and sustainable ingredients, and organic excipients fit the bill perfectly.

Organic excipients, sourced from natural materials like plant-based cellulose, starch, and gums, offer consumers a sense of transparency and assurance in their pharmaceuticals. These excipients are perceived as safer, cleaner, and more environmentally friendly than their synthetic counterparts. They resonate with consumers' desires for holistic health and well-being and cater to their demand for clean-label products free from synthetic and artificial additives.

The clean-label movement extends beyond the food and beverage industry, where it originated, and has made its way into pharmaceuticals. Consumers now prioritize pharmaceutical products that contain recognizable and natural ingredients, which has placed organic excipients in the spotlight.

Additionally, regulatory bodies have taken note of this consumer trend, encouraging pharmaceutical manufacturers to opt for safer and more environmentally friendly excipients in their formulations. The regulatory support for clean-label pharmaceuticals, which often includes organic excipients, further propels their market growth.

Key Market Players

  • Roquette Freres SA
  • DuPont de Nemours Inc.
  • Ashland Inc.
  • BASF SE
  • Kerry Group plc
  • Evonik Industries AG
  • Croda International plc
  • The Lubrizol Corporation
  • Innophos Holdings Inc.
  • Wacker Chemie AG

Report Scope:

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type:

  • Oleochemicals
  • Carbohydrates
  • Petrochemicals
  • Protein
  • Other

Organic Pharmaceutical Excipients Market, By Function:

  • Binders
  • Coating Agents
  • Colorants
  • Disintegrates
  • Other Functions

Organic Pharmaceutical Excipients Market, By Application:

  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Applications

Organic Pharmaceutical Excipients Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Organic Pharmaceutical Excipients Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals; Protein, Other)
    • 4.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
    • 4.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Function
    • 4.3.3. By Application
    • 4.3.4. By Region

5. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Function
    • 5.2.3. By Application
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Organic Pharmaceutical Excipients Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Function
        • 5.3.1.2.3. By Application
    • 5.3.2. India Organic Pharmaceutical Excipients Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Function
        • 5.3.2.2.3. By Application
    • 5.3.3. Australia Organic Pharmaceutical Excipients Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Function
        • 5.3.3.2.3. By Application
    • 5.3.4. Japan Organic Pharmaceutical Excipients Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Function
        • 5.3.4.2.3. By Application
    • 5.3.5. South Korea Organic Pharmaceutical Excipients Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Function
        • 5.3.5.2.3. By Application

6. Europe Organic Pharmaceutical Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Function
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Organic Pharmaceutical Excipients Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Function
        • 6.3.1.2.3. By Application
    • 6.3.2. Germany Organic Pharmaceutical Excipients Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Function
        • 6.3.2.2.3. By Application
    • 6.3.3. Spain Organic Pharmaceutical Excipients Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Function
        • 6.3.3.2.3. By Application
    • 6.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Function
        • 6.3.4.2.3. By Application
    • 6.3.5. United Kingdom Organic Pharmaceutical Excipients Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Function
        • 6.3.5.2.3. By Application

7. North America Organic Pharmaceutical Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Function
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organic Pharmaceutical Excipients Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Function
        • 7.3.1.2.3. By Application
    • 7.3.2. Mexico Organic Pharmaceutical Excipients Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Function
        • 7.3.2.2.3. By Application
    • 7.3.3. Canada Organic Pharmaceutical Excipients Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Function
        • 7.3.3.2.3. By Application

8. South America Organic Pharmaceutical Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Function
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Function
        • 8.3.1.2.3. By Application
    • 8.3.2. Argentina Organic Pharmaceutical Excipients Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Function
        • 8.3.2.2.3. By Application
    • 8.3.3. Colombia Organic Pharmaceutical Excipients Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Function
        • 8.3.3.2.3. By Application

9. Middle East and Africa Organic Pharmaceutical Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Function
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Organic Pharmaceutical Excipients Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Function
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Function
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Organic Pharmaceutical Excipients Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Function
        • 9.3.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Roquette Freres SA
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. DuPont de Nemours Inc.
  • 14.3. Ashland Inc.
  • 14.4. BASF SE
  • 14.5. Kerry Group plc
  • 14.6. Evonik Industries AG
  • 14.7. Croda International plc
  • 14.8. The Lubrizol Corporation
  • 14.9. Innophos Holdings Inc.
  • 14.10. Wacker Chemie AG

15. Strategic Recommendations

16. About Us & Disclaimer